Schlagwörter
AL AMYLOIDOSIS
5
BORTEZOMIB
5
CHEMOTHERAPY
5
CYCLOPHOSPHAMIDE
5
LENALIDOMIDE
5
MAINTENANCE
5
MULTIPLE-MYELOMA
5
NATRIURETIC PEPTIDE
5
PRIMARY SYSTEMIC AMYLOIDOSIS
5
SURVIVAL
5
80 and over
4
Aged
4
Belgium
4
Betacoronavirus
4
COVID-19
4
Coronavirus Infections
4
Female
4
Humans
4
Male
4
Middle Aged
4
Multiple Myeloma
4
Pandemics
4
Pneumonia
4
SARS-CoV-2
4
Surveys and Questionnaires
4
Viral
4